Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, with Black cancer patients twice as likely to test positive for the virus.

Several genetic mutations previously linked to breast cancer and included on commercial genetic tests were found not to increase a woman’s risk of disease, according to a multi-institutional population study of more than 64,000 women.

For more than 10 years, Graciela Gonzalez-Hernandez has been studying natural language across social media to inform clinical care, carefully sifting through language to determine which voices qualify as patient experiences.

A new study finds that combining CAR T thereapy with an enzyme-inhibitor drug allows the engineered cells to battle through jumbled blood vessels and attack tumors.

New research shows a statistically significant increased risk of testicular cancer among those reporting at least three exposures to X-ray, including a colon X-ray, and CT below the waist.

During the pandemic, a Penn-developed algorithm helped sustain end-of-life care discussions with patients with cancer.

A virtual conference on cancer and COVID-19 discussed how medical professionals adapt to a rapidly changing environment and enforce protocols to deliver care safely, while individuals are choosing to skip cancer screenings or delay treatments.

For nearly two decades, a major national study of kidney disease led and coordinated at Penn has defined key risk factors in an all-too-common silent epidemic.

In the era of precision medicine, targeting the mutations driving cancer growth, rather than the tumor site itself, continues to be a successful approach for some patients.

HIV researchers at the Perelman School of Medicine at the University of Pennsylvania and The Wistar Institute will co-lead a five-year, $23 million grant from the National Institutes of Health, as part of the second iteration of the